TS
EXAS

Triglav Skladi’s Exact Sciences EXAS Stock Holding History

Triglav Skladi’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,250
Closed -$790K – 136
2025
Q1 		$790K Hold
18,250
– – 0.07% 107
2024
Q4 		$1.03M Buy
+18,250
New +$1.14M 0.08% 104

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Triglav Skladi's EXAS Position: Q2 2025 in Review

Triglav Skladi sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 18,250 shares — an estimated $790K sold.

Triglav Skladi first reported a position in EXAS in Q4 2024 and held it in 2 quarters. The position peaked at $1.03M in Q4 2024. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Triglav Skladi reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Triglav Skladi sold 18,250 Exact Sciences shares in Q2 2025, an estimated $790K.
  • Triglav Skladi first reported a position in Exact Sciences in Q4 2024 and held it in 2 quarters.
  • Triglav Skladi's Exact Sciences position peaked at $1.03M in Q4 2024.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Triglav Skladi's 13F filing for Q2 2025, filed 5 Aug 2025.